News

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the key takeaways from the ASCO 2025 Annual ...
Taking an active role in your cancer care Talking to your healthcare and support team about your needs Educating yourself You are not the only person responsible for your care. Self-advocacy means ...
Thank You for Contacting Your members of Congress! Let’s build on this momentum – invite your friends and family to [...] READ MORE ...
Today, Dr. Noel is an associate professor of medicine and medical director of the Clinical Research Management Office at Georgetown Lombardi Comprehensive Cancer Center and a member of PanCAN’s ...
Data published in Lancet Oncology in 2020 showed that PanCAN’s Know Your Tumor® precision medicine service can help pancreatic cancer patients live longer. The results showed, for the first time, that ...
American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year..
Editor’s note: With the passing of talk show host and politician Jerry Springer from pancreatic cancer, we wanted to share the common signs and symptoms of the disease. If you or a loved one have been ...
The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...
For eligible patients, surgery is the best option for long term survival of pancreatic cancer.Data show high volume surgeons at high volume hospitals have greater success rates and fewer complications ...
Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...
Two out of every five Americans will be diagnosed with cancer in their lifetime. These are sobering statistics that remind us why investment in cancer research is so critically important for saving ...
For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer.After a clinical trial showed a positive survival benefit, the ...